- Baron is an asset management firm focused on delivering growth equity investment solutions known for long-term, fundamental, active approach to growth investing.
- June and July saw market strength driven by favourable corporate earnings, robust macroeconomic data, and the FDA’s full approval of Pfizer’s COVID-19 vaccine.
- Against this backdrop, Baron Asset Fund declined 0.14%, while the Russell Midcap Growth Index declined 0.76%, and the S&P 500 Index gained 0.58%. The Fund’s outperformance versus the Index was mainly due to differences in sector/ sub-industry weights.
- We invest in stocks that we lieve, based on our deep fundamental research, will double in value over a five-year period, and all new and existing holdings must meet that objective.
For further details see:
Baron Funds Q3 2021 Andrew Peck Letter